ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,787,793 | +17.9% | 65,873 | +33.5% | 0.01% | +22.2% |
| Q2 2023 | $1,516,958 | -14.7% | 49,348 | 0.0% | 0.01% | -18.2% |
| Q1 2023 | $1,778,008 | +42.5% | 49,348 | +56.3% | 0.01% | +37.5% |
| Q4 2022 | $1,247,646 | -38.7% | 31,570 | -37.7% | 0.01% | -42.9% |
| Q3 2022 | $2,035,000 | -58.6% | 50,658 | -56.7% | 0.01% | -56.2% |
| Q2 2022 | $4,918,000 | +1010.2% | 116,983 | +929.5% | 0.03% | +1500.0% |
| Q1 2022 | $443,000 | -2.2% | 11,363 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $453,000 | +10.2% | 11,363 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $411,000 | -27.6% | 11,363 | -18.0% | 0.00% | -33.3% |
| Q2 2021 | $568,000 | -16.0% | 13,861 | -10.6% | 0.00% | -25.0% |
| Q1 2021 | $676,000 | +88.8% | 15,508 | +116.6% | 0.00% | +100.0% |
| Q4 2020 | $358,000 | – | 7,159 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |